The observed improvements in neuropathy measures in AICAR-treated HFD-fed mice could result from its effects on lipid reduction, decreased insulin resistance, better glycemic control, and resistance to weight gain [39,41,42,43]. This evidence concerns the gene INS and neuropathy.